| # | Drug | Count |
|---|---|---|
| 0 | FARICIMAB | 22 |
| 1 | AFLIBERCEPT | 21 |
| 2 | BEVACIZUMAB | 11 |
| 3 | RANIBIZUMAB | 10 |
| 4 | COBIMETINIB | 4 |
| 5 | FLUOCINOLONE ACETONIDE | 4 |
| 6 | DEXAMETHASONE | 3 |
| 7 | SILDENAFIL | 3 |
| 8 | SILDENAFIL CITRATE | 3 |
| 9 | TADALAFIL | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VARDENAFIL HYDROCHLORIDE | 2 | 0.0244 |
| 1 | VARDENAFIL | 2 | 0.0034 |
| 2 | FARICIMAB | 22 | 0.0025 |
| 3 | FLUOCINOLONE ACETONIDE | 4 | 0.0011 |
| 4 | PEGCETACOPLAN | 2 | 0.0011 |
| 5 | COBIMETINIB | 4 | 0.0009 |
| 6 | AFLIBERCEPT | 21 | 0.0007 |
| 7 | MIRVETUXIMAB SORAVTANSINE | 1 | 0.0006 |
| 8 | RANIBIZUMAB | 10 | 0.0004 |
| 9 | TOBRAMYCIN AND DEXAMETHASONE | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Type I Interferon Receptor Antagonist [EPC] | 1 | 0.0005 |
| 1 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 37 | 0.0002 |
| 2 | Carbonic Anhydrase Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Complement Inhibitor [EPC] | 2 | 0.0000 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 3 | 0.0000 |
| 5 | Phosphodiesterase 5 Inhibitor [EPC] | 4 | 0.0000 |
| 6 | Aminoglycoside Antibacterial [EPC] | 1 | 0.0000 |
| 7 | Prostaglandin Analog [EPC] | 2 | 0.0000 |
| 8 | Dietary Cholesterol Absorption Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 1 | 0.0000 |